2-(3-甲基-5-异恶唑基)-2-丙醇 | 138958-55-1

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 唑类
• 中文名称: 2-(3-甲基-5-异恶唑基)-2-丙醇
• 英文名称: 2-(3-methyl-5-isoxazolyl)-2-propanol
• 英文别名: 2-(3-methyl-isoxazol-5-yl)-propan-2-ol；2-(3-Methyl-1,2-oxazol-5-yl)propan-2-ol
• CAS: 138958-55-1
• 化学式: C₇H₁₁NO₂
• 分子量: 141.17
• InChiKey: RRMJIQPBQXMXIM-UHFFFAOYSA-N

物化性质

• 沸点：
  115-116 °C(Press: 22 Torr)
• 密度：
  1.0596 g/cm3(Temp: 27.6 °C)

计算性质

• 辛醇/水分配系数(LogP)：
  0.5
• 重原子数：
  10
• 可旋转键数：
  1
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.57
• 拓扑面积：
  46.3
• 氢给体数：
  1
• 氢受体数：
  3

反应信息

• 作为反应物：
  描述：

  2-(3-甲基-5-异恶唑基)-2-丙醇 在 palladium on activated charcoal 盐酸 、 sodium hydroxide 、 氢气 作用下， 以 乙醇 为溶剂， 反应 26.0h， 生成 (E)-2,2-dimethyl-5-(2-phenylethenyl)-3(2H)-furanone
  参考文献：
  名称：

  Synthesis and antiulcer activity of novel 5-(2-ethenyl substituted)-3(2H)-furanones

  摘要：

  In order to investigate new antiulcer agents, spizofurone 1 (AG-629) was fragmented and reassembled to generate 5-phenyl-2,2-dimethyl-3(2H)-furanone (bullatenone, 2). Because of the antiulcer activity of 2,5-phenyl-substituted 2,2-dimethyl-3(2H)-furanones (3-6) were made and shown to have poor activity. Insertion of an ethenyl link between the furanone and phenyl rings gave 5-(2-phenylethenyl)-2,2-dimethyl-3(2H)-furanone (7). This compound had better activity than 2. Compounds 8-41 were synthesized to evaluate the SAR in 5-(2-ethenyl substituted)-3(2H)-furanones. Electron-withdrawing substituents on the aromatic ring (8, 10, 19, and 20) gave 2-3-fold higher activity. Further increases in the activity were found when the phenyl ring was replaced by heterocyclic nuclei. Compounds that contained a thiophene (29), pyridine (24-26), or quinoline ring (32) had the best activity. Replacement of the methyl group on the furanone ring with a phenyl (34) or p-fluorophenyl (40) substituent in the 2-pyridine series gave compounds with activity that ranked with the best obtained in this study. The best compounds from the above SAR studies were evaluated in the ethanol-necrosis model for duration of cytoprotection action. Compounds 19, 24, and 29, which had the best duration of action, were tested with AG-629 in the acidified aspirin and indomethacin-induced lesion models. Only compound 24 had equivalent activity with AG-629 in both models.

  DOI：

  10.1021/jm00085a003
• 作为产物：
  描述：

  (E)-acetaldoxime 、 2-甲基-3-丁炔-2-醇 在 sodium hypochlorite 、 三乙胺 作用下， 以 氯仿 为溶剂， 生成 2-(3-甲基-5-异恶唑基)-2-丙醇
  参考文献：
  名称：

  来自7-（2-氧乙氧基）香豆素的新geiparvarin类似物可作为有效的体外抗肿瘤药

  摘要：

  描述了一种新的盖帕瓦林类似物的化合物类似物：3（2 H）-呋喃酮和7-（2-氧代乙氧基）香豆素的醛缩合反应，然后通过非常有效的脱水步骤，可得到标题化合物，该化合物显示出对几种人的良好抗肿瘤活性细胞系。

  DOI：

  10.1016/s0040-4039(02)01798-7

文献信息

• [EN] SUBSTITUTED PYRAZOLYL[4,3-C]PYRIDINECOMPOUNDS AS RET KINASE INHIBITORS<br/>[FR] COMPOSÉS DE PYRAZOLYL[4,3-C]PYRIDINE SUBSTITUÉS UTILISÉS EN TANT QU'INHIBITEURS DE LA KINASE RET
  申请人：ARRAY BIOPHARMA INC

  公开号：WO2019143994A1

  公开（公告）日：2019-07-25

  Provided herein are compounds of the Formula I: and tautomers and pharmaceutically acceptable salts and solvates thereof, wherein R1, R2 and R3 have the meanings given in the specification, which are inhibitors of RET kinase and are useful in the treatment and prevention of diseases which can be treated with a RET kinase inhibitor, including RET-associated diseases and disorders.

  提供以下式I的化合物：及其互变异构体和药用可接受的盐和溶剂化物，其中R1、R2和R3具有说明书中给出的含义，它们是RET激酶的抑制剂，可用于治疗和预防可通过RET激酶抑制剂治疗的疾病，包括RET相关疾病和失调。
• New geiparvarin analogues from 7-(2-oxoethoxy)coumarins as efficient in vitro antitumoral agents
  作者：Stefano Chimichi、Marco Boccalini、Barbara Cosimelli、Giampietro Viola、Daniela Vedaldi、Francesco Dall'Acqua

  DOI：10.1016/s0040-4039(02)01798-7

  日期：2002.10

  A new class of compounds analogues of geiparvarin is described: aldolic condensation of 3(2H)-furanones and 7-(2-oxoethoxy)coumarins followed by a very efficient dehydration protocol led to the title compounds which show good antitumoral activity against several human cell lines.

  描述了一种新的盖帕瓦林类似物的化合物类似物：3（2 H）-呋喃酮和7-（2-氧代乙氧基）香豆素的醛缩合反应，然后通过非常有效的脱水步骤，可得到标题化合物，该化合物显示出对几种人的良好抗肿瘤活性细胞系。
• [EN] PYRIDAZINE DERIVATIVES AS RORc MODULATORS<br/>[FR] DÉRIVÉS DE PYRIDAZINE EN TANT QUE MODULATEURS DE RORC
  申请人：HOFFMANN LA ROCHE

  公开号：WO2016177686A1

  公开（公告）日：2016-11-10

  Compounds of formula (I): or pharmaceutical salts thereof, wherein m, n, A, R1, R2, R3, R4 and R5 are as defined herein. Also disclosed are methods of making the compounds and using the compounds for treatment of inflammatory diseases such as arthritis.

  公式（I）的化合物：或其药用盐，其中m、n、A、R1、R2、R3、R4和R5的定义如本文所述。还公开了制备这些化合物的方法，并将这些化合物用于治疗炎症性疾病，如关节炎。
• Musante, Gazzetta Chimica Italiana, 1941, vol. 71, p. 172,180
  作者：Musante

  DOI：——

  日期：——
• SUBSTITUTED PYRROLO[2,3-D]PYRIMIDINES COMPOUNDS AS RET KINASE INHIBITORS
  申请人：Array BioPharma Inc.

  公开号：US20200339589A1

  公开（公告）日：2020-10-29

  Provided herein are compounds of the Formula I: [INSERT FORMULA I] and tautomers, stereoisomers and pharmaceutically acceptable salts and solvates thereof, wherein R1, R2 and Ry have the meanings given in the specification, which are inhibitors of RET kinase and are useful in the treatment and prevention of diseases which can be treated with a RET kinase inhibitor, including RET-associated diseases and disorders.